Big Pharma Split (TSX:PRM) Selling and Marketing Expense : C$0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Big Pharma Split Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Big Pharma Split's Selling and Marketing Expense for the six months ended in Jun. 2024 was C$0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 was C$0.00 Mil.

Big Pharma Split Selling and Marketing Expense Historical Data

The historical data trend for Big Pharma Split's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Selling and Marketing Expense Chart

Big Pharma Split Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Selling and Marketing Expense

Get a 7-Day Free Trial

Big Pharma Split Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Selling and Marketing Expense	Get a 7-Day Free Trial									-	-	-	-	-

Big Pharma Split Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Big Pharma Split Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Big Pharma Split's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Big Pharma Split Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (TSX:PRM) » Definitions » Selling and Marketing Expense

Comparable Companies

Traded in Other Exchanges

XN4:Germany PRM.PR.A.PFD:Canada

Address

610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5

Website

https://www.harvestportfolios.com

Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Executives

Michael Kovacs

Director, Senior Officer